Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
i2 New
Etobicoke, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
i2 New appears to be a small healthcare-related company associated with Ryan J. Foley and linked in public records and directory listings to Canada and Ireland. Available evidence suggests it is not a drug-development biotech or pharmaceutical company, but rather a health-oriented commercial or consulting entity connected to the broader consumer health and supplement ecosystem around NuvoCare Health Sciences. Publicly available information on products, pipeline assets, clinical programs, and scientific platform technologies is very limited. As a result, i2 New is best characterized as a healthcare-related private company with unclear current operating scope rather than a therapeutics developer.
- Industry
- Food & Nutrition
Beyond the preview
Go deeper on i2 New.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on i2 New.